IVX

AMD Reshapes Automotive Industry with Advanced AI Engines and Elevated In-Vehicle Experiences at CES 2024

Retrieved on: 
Thursday, January 4, 2024
Urinary tract infection, Paramount, QNX, Lidar, Ecosystem, Classification, Consumer Electronics Show, Software, QT, Android Automotive, Makalu, Radeon, Acquisition, BlackBerry, AMD, Electronics, Multi, Research, Visteon, AI, Automotive Grade Linux, Workplace, Socs, Artificial intelligence, IP, SOC, Ryzen, Safety, CES, IVX, Embedded, Video game

SANTA CLARA, Calif., Jan. 04, 2024 (GLOBE NEWSWIRE) -- Today, AMD (NASDAQ: AMD) announced it will showcase automotive innovation at CES 2024 and expand its portfolio with the introduction of two new devices, the Versal™ AI Edge XA adaptive SoC and Ryzen™ Embedded V2000A Series processor. The devices underscore AMD automotive technology leadership and are designed to serve key automotive focus segments including infotainment, advanced driver safety and autonomous driving. Working alongside a growing automotive partner ecosystem, AMD will demonstrate at CES 2024 the broad range of capabilities and applications for these new devices in automotive solutions available today and in the future.

Key Points: 
  • The devices underscore AMD automotive technology leadership and are designed to serve key automotive focus segments including infotainment, advanced driver safety and autonomous driving.
  • Working alongside a growing automotive partner ecosystem, AMD will demonstrate at CES 2024 the broad range of capabilities and applications for these new devices in automotive solutions available today and in the future.
  • The AI Engines are capable of handling different types of AI models such as classification and feature tracking.
  • Visit the AMD booth at LVCC West Hall #W319 at CES 2024 to learn more about AMD automotive solutions and speak with AMD experts.

EQS-News: InVision AG Releases Nine-Months Figures and Provides Concrete Outlook for 2023 Fiscal Year

Retrieved on: 
Thursday, December 28, 2023
Invision, Frankfurt Stock Exchange, Growth, IVX, Lithium

Düsseldorf (Germany), 30th November 2023 - InVision AG (ISIN: DE0005859698) today reported its financial results for the first nine months of the current fiscal year.

Key Points: 
  • Düsseldorf (Germany), 30th November 2023 - InVision AG (ISIN: DE0005859698) today reported its financial results for the first nine months of the current fiscal year.
  • Compared to the previous year, this corresponds to a growth of 9 percent (9M 2022: EUR 10.724 million).
  • The operating cash flow rose from minus EUR 0.294 million (9M 2022) to plus EUR 0.794 million.
  • Liquid funds increased by 9 percent to EUR 7.105 million as of 30 September 2023 (31 December 2022: EUR 6.489 million).

Trellix Extends Virtual Intrusion Prevention System with AWS Gateway Load Balancer

Retrieved on: 
Monday, December 4, 2023
Data Management, Security, Technology, Software, Networks, Internet, Amazon Web Services, VIPS, Email, XDR, Igneous intrusion, AWS, Virtual, IVX, Risk management, Trellix

Trellix , the cybersecurity company delivering the future of extended detection and response (XDR), today announced its enhanced Virtual Intrusion Prevention System (vIPS) 11.1.x integration with AWS Gateway Load Balancer (GWLB) from Amazon Web Services (AWS).

Key Points: 
  • Trellix , the cybersecurity company delivering the future of extended detection and response (XDR), today announced its enhanced Virtual Intrusion Prevention System (vIPS) 11.1.x integration with AWS Gateway Load Balancer (GWLB) from Amazon Web Services (AWS).
  • The integration streamlines migration to the cloud by offering ease of deployment and enhanced capabilities to handle fluctuating traffic loads.
  • Trellix IPS+ adds the Trellix Intelligent Virtual Execution (IVX) analysis engine, allowing signatureless (sandbox detonation) detection and behavioral analysis to help identify the most elusive and emerging threats.
  • High Performance: Throughput of up to 1Gbps per sensor with unlimited sensors and automatic scale-in and scale-out to adapt to elastic workloads.

Commvault Joins Forces with Leading Security, AI Companies to Help Customers Stay Ahead of Bad Actors and Escalating Cyber Threats

Retrieved on: 
Wednesday, November 8, 2023
Cloud, Sentinel, Cortex, Intelligence, SIEM, KMS, SASE, ESG, SOAR, IDC, Commvault, Organization, Entrust, Research, Cognition and Neuroergonomics (CaN) Collaborative Technology Alliance, API, Artificial intelligence, Environment, Growth, Ecosystem, SECS/GEM, Privacy, Darktrace, Confidentiality, AI, QA, IVX, Trellix, Automation, Risk management, Video game, Medical device, Cryptocurrency, New Jersey Cybersecurity and Communications Integration Cell

NEW YORK, Nov. 8, 2023 /PRNewswire/ -- COMMVAULT SHIFT -- Commvault, a leading provider of data protection and cyber resilience solutions for hybrid cloud organizations, today announced that it's marrying modern cyber resilience technologies from Commvault with advanced security and data intelligence from pioneers in cybersecurity, artificial intelligence, and cloud.

Key Points: 
  • The timing of these security and AI integrations is ideal as companies face unprecedented volumes of cyber threats and have major concerns about what bad actors can do in terms of business disruption and brand reputations.
  • Databricks: combines the best of data warehouses and data lakes to offer an open and unified platform for data and AI.
  • Netskope: a global SASE cybersecurity leader, helps organizations apply zero trust principles and AI/ML innovations to protect data and defend against cyber threats.
  • "The planned integration between Darktrace HEAL™ and the Commvault Cloud platform will provide our joint customers with robust tools that help them prepare for, respond to and recover from potential cyber threats."

IVX Health Announces North Carolina Expansion with Two New Infusion Centers in Piedmont Triad

Retrieved on: 
Thursday, October 19, 2023
Practitioner, Modern Healthcare, Health, Neurology, Rheumatology, Gastroenterology, Growth, Piedmont Triad, The Last Best Place, Television, Patient, IVX, Diagnosis, Pharmaceutical industry, Nursing, Health care

GREENSBORO, N.C., Oct. 19, 2023 /PRNewswire/ -- IVX Health , a national provider of outpatient infusion and injection centers, today announced its continued expansion in North Carolina with two new infusion centers opening in Greensboro and Winston-Salem.

Key Points: 
  • GREENSBORO, N.C., Oct. 19, 2023 /PRNewswire/ -- IVX Health , a national provider of outpatient infusion and injection centers, today announced its continued expansion in North Carolina with two new infusion centers opening in Greensboro and Winston-Salem.
  • The addition of the Piedmont Triad market brings IVX Health's existing North Carolina footprint to eight centers across three markets — and growing.
  • "We are thrilled to continue expanding our footprint in North Carolina with the opening of the Piedmont Triad market," said Jennifer LaMar, regional operations director with IVX Health.
  • "I have been receiving infusions at IVX Health for the past three years," said Cam Wiggins, current biologic patient at IVX Health.

IVX Health Opens Two New Infusion Centers to Serve Patients in Little Rock

Retrieved on: 
Thursday, October 5, 2023
Diagnosis, Crohn's disease, Health, Rheumatoid arthritis, Immunodeficiency, ROCK, Gastroenterology, IVX, Rheumatology, Multiple sclerosis, Wi-Fi, Neurology, Patient, Sclerosis, Practitioner, Nursing, Medical device

LITTLE ROCK, Ark., Oct. 5, 2023 /PRNewswire/ -- IVX Health , a national provider of outpatient infusion and injection centers, today announced the opening of two new infusion centers in the greater Little Rock area.

Key Points: 
  • LITTLE ROCK, Ark., Oct. 5, 2023 /PRNewswire/ -- IVX Health , a national provider of outpatient infusion and injection centers, today announced the opening of two new infusion centers in the greater Little Rock area.
  • The two new Little Rock centers complement IVX Health's existing footprint in Arkansas and across the Midwest .
  • "IVX Health provides top-notch care for patients and referring physicians, with a commitment to clinical excellence and a truly world-class patient experience," said Ashley Riley, regional vice president at IVX Health.
  • All IVX Health patients are guaranteed a private infusion suite, equipped with the same safety protocols as a traditional hospital infusion setting.

IVX Health Announces Five New Infusion Centers Across Miami to Care for Patients with Complex Chronic Conditions

Retrieved on: 
Thursday, September 14, 2023
Television, Health, Diagnosis, IVX, Patient, Practitioner, Drug, Nursing, Sweetwater

The addition of the Miami market brings IVX Health's existing Florida footprint to 27 centers across 10 markets — and growing.

Key Points: 
  • The addition of the Miami market brings IVX Health's existing Florida footprint to 27 centers across 10 markets — and growing.
  • IVX's infusion centers in Miami will be conveniently located in Doral, Hallandale Beach, Kendall, South Miami, and Sweetwater.
  • The South Miami and Sweetwater infusion centers previously operated under the brand InfuseWell prior to IVX Health's ownership beginning in September 2023.
  • "I have been receiving infusions at IVX Health for the past three years," said Cam Wiggins, current biologic patient at IVX Health.

EQS-News: InVision AG Applies for Change to the General Standard Segment of German Stock Exchange's Regulated Market

Retrieved on: 
Thursday, August 31, 2023
ISIN, Saskatchewan River Sturgeon Management Board, IVX, Supervisory board, Frankfurt Stock Exchange, Invision, Security (finance)

Düsseldorf (Germany), 31st August 2023 - The Management Board of InVision AG (ISIN: DE0005859698) has decided, with the approval of the Supervisory Board, to apply for the withdrawal of admission to trading in the Prime Standard of the Frankfurt Stock Exchange.

Key Points: 
  • Düsseldorf (Germany), 31st August 2023 - The Management Board of InVision AG (ISIN: DE0005859698) has decided, with the approval of the Supervisory Board, to apply for the withdrawal of admission to trading in the Prime Standard of the Frankfurt Stock Exchange.
  • The segment change, as a result of which the additional post-admission obligations of the marketplace will no longer apply, is intended to realise cost savings.
  • Since 1995, InVision has been helping its clients to increase their productivity and quality of work and reduce their costs.
  • InVision AG (IVX) is listed in the Prime Standard Segment of the Frankfurt Stock Exchange.

IVX Health Announces New Infusion Center in Delaware

Retrieved on: 
Wednesday, August 30, 2023
Health, Crohn's disease, IVX, Diagnosis, Growth, Patient, Practitioner, Nursing, Multiple sclerosis, Rheumatoid arthritis

"IVX Health is thrilled to have a presence in Delaware," said Matt Munden, director of nursing for IVX Health.

Key Points: 
  • "IVX Health is thrilled to have a presence in Delaware," said Matt Munden, director of nursing for IVX Health.
  • "Our Wilmington center – just like all IVX centers nationwide – has an incredibly caring and talented nursing team that specializes exclusively in infusion and injection therapy.
  • This clinical expertise is one of the many reasons we believe there is no safer place to receive ongoing specialty biologics than IVX Health."
  • "After my multiple sclerosis diagnosis, my neurologist recommended that I begin infusion treatment at IVX, and life changed after that," said Cam Wiggins, current biologic patient at IVX Health.

EQS-News: InVision AG Publishes Consolidated Interim Financial Statements for the First Half of 2023

Retrieved on: 
Thursday, August 24, 2023
ISIN, EUR, IVX, Frankfurt Stock Exchange, EBIT, Earnings before interest and taxes, Invision, Bank statement, Lithium, Tax

Düsseldorf (Germany), 24th August 2023 - InVision AG (ISIN: DE0005859698) today published its consolidated interim financial statements for the first half of the current fiscal year.

Key Points: 
  • Düsseldorf (Germany), 24th August 2023 - InVision AG (ISIN: DE0005859698) today published its consolidated interim financial statements for the first half of the current fiscal year.
  • In the first six months of 2023, total revenues amounted to EUR 7.765 million, which corresponds to an increase of 9 percent compared to the first half of 2022 (6M 2022: EUR 7.092 million).
  • The Operating cash flow increased by 52 percent to EUR 1.826 million (6M 2022: EUR 1.205 million).
  • The Company’s Consolidated Interim Statements for the first first half of the 2023 financial year are now available on the Company’s website at: www.ivx.com/en/investors/financial-reports .